Ashley Hall - Net Worth and Insider Trading
Ashley Hall Net Worth
The estimated net worth of Ashley Hall is at least $72,072 dollars as of 2024-12-27. Ashley Hall is the Chief Development Officer of Reneo Pharmaceuticals Inc and owns about 3,960 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $72,072. Details can be seen in Ashley Hall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ashley Hall has not made any transactions after 2023-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ashley Hall
Ashley Hall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ashley Hall owns 2 companies in total, including Esperion Therapeutics Inc (ESPR) , and Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Ashley Hall’s form 4 insider trades.
Insider Ownership Summary of Ashley Hall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2020-02-26 | Chief Development Officer |
| RPHM | Reneo Pharmaceuticals Inc | 2023-08-28 | Chief Development Officer |
Ashley Hall Latest Holdings Summary
Ashley Hall currently owns a total of 1 stock. Ashley Hall owns 3,960 shares of Reneo Pharmaceuticals Inc (RPHM) as of August 28, 2023, with a value of $72,072.
Latest Holdings of Ashley Hall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2023-08-28 | 3,960 | 18.20 | 72,072 |
Holding Weightings of Ashley Hall
Ashley Hall Form 4 Trading Tracker
According to the SEC Form 4 filings, Ashley Hall has made a total of 1 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the sale of 1,563 shares on August 28, 2023, which brought Ashley Hall around $98,125.
Insider Trading History of Ashley Hall
- 1
Ashley Hall Trading Performance
Ashley Hall Ownership Network
Ashley Hall Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Ashley Hall is the Chief Development Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Financial Officer Benjamin Halladay , Chief Operating Officer Sheldon L. Koenig , and Chief Commercial Officer Eric Warren .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Ashley Hall made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 9,288 shares made by Eric Warren , a net sale of 26,997 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .
In summary, during the past 3 months, insiders sold 18,230 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,230 shares. During the past 18 months, 43,732 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,732 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Ashley Hall Mailing Address
Above is the net worth, insider trading, and ownership report for Ashley Hall. You might contact Ashley Hall via mailing address: C/o Esperion Therapeutics Inc., 3891 Ranchero Drive Suite 150, Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
